- Home
- HITI vs SCPH Comparison
HITI vs SCPH Comparison
Compare HITI & SCPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HITI
- SCPH
- Stock Information
- Founded
- HITI 2009
- SCPH 2013
- Country
- HITI Canada
- SCPH United States
- Employees
- HITI N/A
- SCPH N/A
- Industry
- HITI
- SCPH Biotechnology: Pharmaceutical Preparations
- Sector
- HITI
- SCPH Health Care
- Exchange
- HITI Nasdaq
- SCPH Nasdaq
- Market Cap
- HITI 187.8M
- SCPH 173.6M
- IPO Year
- HITI N/A
- SCPH 2017
- Fundamental
- Price
- HITI $2.39
- SCPH $4.46
- Analyst Decision
- HITI Strong Buy
- SCPH Strong Buy
- Analyst Count
- HITI 2
- SCPH 3
- Target Price
- HITI $4.75
- SCPH $14.00
- AVG Volume (30 Days)
- HITI 336.4K
- SCPH 276.4K
- Earning Date
- HITI 06-16-2025
- SCPH 08-13-2025
- Dividend Yield
- HITI N/A
- SCPH N/A
- EPS Growth
- HITI N/A
- SCPH N/A
- EPS
- HITI N/A
- SCPH N/A
- Revenue
- HITI $398,202,371.00
- SCPH $41,982,000.00
- Revenue This Year
- HITI $12.43
- SCPH $108.95
- Revenue Next Year
- HITI $11.39
- SCPH $73.83
- P/E Ratio
- HITI N/A
- SCPH N/A
- Revenue Growth
- HITI 9.22
- SCPH 138.10
- 52 Week Low
- HITI $1.57
- SCPH $1.94
- 52 Week High
- HITI $3.62
- SCPH $5.65
- Technical
- Relative Strength Index (RSI)
- HITI 55.72
- SCPH 60.01
- Support Level
- HITI $2.26
- SCPH $3.83
- Resistance Level
- HITI $2.44
- SCPH $4.18
- Average True Range (ATR)
- HITI 0.08
- SCPH 0.17
- MACD
- HITI 0.01
- SCPH -0.02
- Stochastic Oscillator
- HITI 71.19
- SCPH 76.60
About HITI High Tide Inc.
High Tide Inc is a downstream-focused retailer of cannabis products, distributor, and seller of smoking accessories and cannabis lifestyle products. It is a vertically integrated company in the Canadian cannabis market with various brands in its portfolio such as Canna Cabana, Fastendr, Queen of Bud, Grasscity, Daily High Club, Famous Brandz, and others. The company's reportable operating segments are; Bricks and mortar which generates maximum revenue, and E-commerce. Geographically, it derives maximum revenue from its business in Canada followed by the United States of America, and other international markets.
About SCPH scPharmaceuticals Inc.
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.